Related Experiment Videos
Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone
1Laboratory of Viral Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Biochemical and Biophysical Research Communications
|May 15, 1989
Summary
5,6,7-Trihydroxyflavone (baicalein) significantly inhibits murine leukemia virus (MLV) and human immunodeficiency virus (HIV) reverse transcriptases. This natural compound acts competitively against template-primer, offering potential antiviral applications.
Area of Science:
- Biochemistry
- Virology
- Pharmacology
Background:
- Reverse transcriptase is a key enzyme in retroviral replication, making it a target for antiviral therapies.
- 5,6,7-Trihydroxyflavone (baicalein) is a plant-derived flavonoid with known biological activities.
Purpose of the Study:
- To investigate the inhibitory effects of baicalein on MLV and HIV reverse transcriptase activities.
- To determine the mode and kinetics of baicalein's inhibition.
Main Methods:
- Enzyme inhibition assays were performed using MLV and HIV reverse transcriptase.
- Kinetic analysis was conducted to determine the mode of inhibition and inhibition constants (Ki).
Main Results:
- Baicalein inhibited both MLV and HIV reverse transcriptase activities by over 90% at 2 µg/ml.
- The inhibition was competitive with respect to the template:primer and noncompetitive with respect to the dTTP substrate.
- The Ki value for baicalein against MLV-reverse transcriptase was determined to be 0.37 µM.
Conclusions:
- Baicalein is a potent inhibitor of MLV and HIV reverse transcriptases.
- Its specific mode of inhibition suggests a potential role in developing novel antiviral agents targeting these enzymes.